Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
IONS Ionis Pharmaceuticals
- 31.040
- +0.690+2.27%
Close Feb 14 16:00 ET
- 31.040
- 0.0000.00%
Post 20:01 ET
4.90BMarket Cap-12.72P/E (TTM)
31.600High30.370Low1.45MVolume30.490Open30.350Pre Close44.64MTurnover0.92%Turnover RatioLossP/E (Static)157.90MShares52.34052wk High7.40P/B4.86BFloat Cap30.23052wk Low--Dividend TTM156.52MShs Float86.582Historical High--Div YieldTTM4.05%Amplitude2.500Historical Low30.878Avg Price1Lot Size
About Ionis Pharmaceuticals Company
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Company Profile
SymbolIONS
Company NameIonis Pharmaceuticals
Listing DateApr 17, 1991
Issue Price57.56
Founded1989
CEODr. Brett P. Monia, PhD
MarketNASDAQ
Employees927
Fiscal Year Ends12-31
Address2855 Gazelle Court
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92010
Phone1-760-931-9200
Websitehttp://www.ionis.com
Company Executives
- Name
- Position
- Salary
- Dr. Brett P. Monia, PhD
- Chief Executive Officer and Director
- 12.50M
- Patrick R. O'Neil, Esq.
- Chief Legal Officer, General Counsel and Corporate Secretary
- --
- Eugene Schneider
- Executive Vice President and Chief Clinical Development and Operations Officer
- --
- Elizabeth L. Hougen
- Executive Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
- 2.89M
- Dr. C. Frank Bennett,PhD
- Executive Vice President and Chief Scientific Officer
- --
- Joseph T. Baroldi
- Executive Vice President and Chief Business Officer
- --
- Dr. Richard S. Geary,PhD
- Executive Vice President and Chief Development Officer
- 2.56M
- Brian Birchler
- Executive Vice President, Corporate and Development Operations
- --
- Eric E. Swayze, PhD
- Executive Vice President, Research
- 2.56M
- Kyle Jenne
- Executive Vice President, Commercial
- --
- Dr. Joseph Loscalzo, M.D.,PhD
- Chairman of the Board
- 568.04K
- B. Lynne Parshall, Esq.,J.D.
- Director
- 538.04K
- Joan E. Herman
- Independent Director
- 540.04K
- Allene M. Diaz
- Independent Director
- 530.04K
- Joseph H. Wender
- Lead Independent Director
- 598.04K
- Michael J. Yang
- Independent Director
- 363.05K
- Joseph Klein, III
- Independent Director
- 542.04K
- Dr. Spencer R. Berthelsen,M.D.
- Independent Director
- 548.04K
- Dr. Michael Hayden
- Independent Director
- 528.04K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.